Literature DB >> 20981032

Expression of N-type calcium channels in human adrenocortical cells and their contribution to corticosteroid synthesis.

Shizuka Aritomi1, Hirotaka Wagatsuma, Tomohiro Numata, Yoshitsugu Uriu, Yasuko Nogi, Akira Mitsui, Tomoyuki Konda, Yasuo Mori, Michihiro Yoshimura.   

Abstract

The inhibition of aldosterone activity is a useful approach for preventing the progression of cardiovascular and renal diseases in hypertensive patients. Although the results of our previous in vivo study suggested that N-type calcium channels may have a role in regulating plasma aldosterone levels, the direct relationship between N-type calcium channels and aldosterone production in adrenocortical cells has not been examined. In this study, the analysis of quantitative reverse transcription-PCR, western blotting, and immunocytological staining indicated the possible presence of N-type calcium channels in human adrenocortical cells (H295R cell line). Patch clamp analysis indicated that omega-conotoxin GVIA (CnTX), an N-type calcium channel inhibitor, suppressed voltage-dependent barium currents. During steroidogenesis, CnTX significantly reduced the transient calcium signaling induced by angiotensin II (Ang II) and partially prevented Ang II-induced aldosterone and cortisol formation with no significant influence on CYP11B2 and CYP11B1 mRNA expression. In addition, in α1B calcium channel subunits, knockdown significantly decreased Ang II-induced aldosterone formation with increments in CYP11B2 mRNA expression. We also investigated the inhibitory activities of some types of dihydropyridine calcium channel blockers (CCBs; cilnidipine: L-/N-type CCB, efonidipine: L-/T-type CCB, and nifedipine: L-type CCB), and these agents showed a dose-dependent inhibition effect on Ang II-induced aldosterone and cortisol production. Furthermore, only cilnidipine failed to suppress CYP11B1 expression in H295R cells. These results suggest that N-type calcium channels have a significant role in transducing the Ang II signal for aldosterone (and cortisol) biosynthesis, which may explain the mechanism by which N-type calcium channels regulate plasma aldosterone levels.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20981032     DOI: 10.1038/hr.2010.191

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  16 in total

1.  L/N-type calcium channel blocker suppresses reflex aldosterone production induced by antihypertensive action.

Authors:  Shizuka Aritomi; Tomoyuki Konda; Michihiro Yoshimura
Journal:  Heart Vessels       Date:  2011-10-12       Impact factor: 2.037

2.  An N-/L-type calcium channel blocker, cilnidipine, suppresses autonomic, electrical, and structural remodelling associated with atrial fibrillation.

Authors:  Kazuko Tajiri; Jean-Baptiste Guichard; Xiaoyan Qi; Feng Xiong; Patrice Naud; Jean-Claude Tardif; Antoine Da Costa; Kazutaka Aonuma; Stanley Nattel
Journal:  Cardiovasc Res       Date:  2019-12-01       Impact factor: 10.787

3.  L/N-type Ca2+ channels blocker cilnidipine ameliorated the repolarization abnormality in a chronic hemodialysis patient.

Authors:  Xin Cao; Yuji Nakamura; Takeshi Wada; Hiroko Izumi-Nakaseko; Kentaro Ando; Atsushi Sugiyama
Journal:  Heart Vessels       Date:  2016-06-20       Impact factor: 2.037

4.  L/N-type calcium channel blocker cilnidipine reduces plasma aldosterone, albuminuria, and urinary liver-type fatty acid binding protein in patients with chronic kidney disease.

Authors:  Masanori Abe; Noriaki Maruyama; Hiroko Suzuki; Atsushi Inoshita; Yoshinori Yoshida; Kazuyoshi Okada; Masayoshi Soma
Journal:  Heart Vessels       Date:  2012-08-23       Impact factor: 2.037

5.  Long-term effects of L- and N-type calcium channel blocker on uric acid levels and left atrial volume in hypertensive patients.

Authors:  Mitsuru Masaki; Toshiaki Mano; Akiyo Eguchi; Shohei Fujiwara; Masataka Sugahara; Shinichi Hirotani; Takeshi Tsujino; Kazuo Komamura; Masahiro Koshiba; Tohru Masuyama
Journal:  Heart Vessels       Date:  2016-01-29       Impact factor: 2.037

6.  NCI-H295R, a human adrenal cortex-derived cell line, expresses purinergic receptors linked to Ca²⁺-mobilization/influx and cortisol secretion.

Authors:  Haruhisa Nishi; Hirokazu Arai; Toshihiko Momiyama
Journal:  PLoS One       Date:  2013-08-08       Impact factor: 3.240

7.  Comparison of the cardioprotective and renoprotective effects of the L/N-type calcium channel blocker, cilnidipine, in adriamycin-treated spontaneously-hypertensive rats.

Authors:  Shizuka Aritomi; Eri Harada; Kazumi Sugino; Mai Nishimura; Tarou Nakamura; Akira Takahara
Journal:  Clin Exp Pharmacol Physiol       Date:  2015-04       Impact factor: 2.557

8.  Ca2+ and K+ channels of normal human adrenal zona fasciculata cells: properties and modulation by ACTH and AngII.

Authors:  John J Enyeart; Judith A Enyeart
Journal:  J Gen Physiol       Date:  2013-07-15       Impact factor: 4.086

9.  Effect of a novel calcium channel blocker on abnormal nocturnal blood pressure in hypertensive patients.

Authors:  Kazuomi Kario; Jin Nariyama; Hidenori Kido; Shin-ichi Ando; Shin Takiuchi; Kazuo Eguchi; Yawara Niijima; Toshiaki Ando; Makoto Noda
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-04-29       Impact factor: 3.738

10.  Suppression of aldosterone synthesis and secretion by ca(2+) channel antagonists.

Authors:  Keiichi Ikeda; Tsuyoshi Isaka; Kouki Fujioka; Yoshinobu Manome; Katsuyoshi Tojo
Journal:  Int J Endocrinol       Date:  2012-10-11       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.